Doctors ask for proof of anti-cancer properties in cannabis oil
May 23rd, 2013
Categories : Blog
Medical Doctors Ask For More Proof of Possible Anti-Cancer Properties in Cannabis Oil
The scientific community is publishing in increasing number of credible journal articles supporting another medical use of marijuana. Some studies are supporting the theory that cannabinoids have anti-tumor effects on the cellular level and in animals.
Treatment consists of Cannabis oil, or extract, which contains a concentration of fifty percent or more THC and/or CBD. This extract is being used to treat a variety of health conditions. These range from skin problems to cancerous tumors.
Cannabis users are supply plenty of anecdotal success reports. Doctors need to know if they are scientifically valid though. These reports are becoming more credible as they are joined by actual scientific journal articles which demonstrate a link between the use of cannabinoids and the treatment of some tumors. These studies have studied anti-tumor treatments by researching the effects of cannabinoids on animals at the cellular level.
The topic of using cannabinoids as a cancer treatment was repeated more than once at the annual meeting of the International Cannabinoid Research Society.
The University of California at San Francisco also presented a course for medical doctors. One medical doctor who presented at this course, Dr. Jeffrey Hergenrather, reported a local San Francisco case. A local baby enjoyed a ninety percent reduction in the size of a brain tumor after a year of receiving hemp oil on a pacifier before sleep over the course of a year.
This half-day medical course was coded “MMJ13001A” on the school website of the University of California at San Francisco. It included presentations by three separate medical researchers who believe their personal research about the health benefits of cannabis oil has been ignored by the medical and other scientists. Stephen Sidney, MD, director of research for Kaiser-Permanente in Northern California, UCLA pulmonologist Donald Tashkin, MD, and Donald Abrams, MD, Chief of Hematology-Oncology at San Francisco General Hospital are the three researchers.
This University of California at San Francisco course qualified sixty medical doctors for continuing medical education (CE) credit. The course was organized by the Canadian Consortium for the Investigation of Cannabinoids. Abrams and the Society of Cannabis Clinicians also provide support. The popular course was repeated the next day in Santa Monica, California as well.